These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15486137)

  • 1. Secondary prevention of coronary heart disease in South Wales: a survey following myocardial infarction.
    Underwood PM; Cozma LS; Laji K; Cohen H; Oboubie K; Beck P
    Heart; 2004 Nov; 90(11):1332-3. PubMed ID: 15486137
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions to manage coronary heart disease.
    Parkinson D
    Nurs Times; 2003 Jul 8-14; 99(27):48-9. PubMed ID: 12882058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of CHD.
    Nelson MR; Tonkin A
    Aust Fam Physician; 2005 Jun; 34(6):433-40. PubMed ID: 15931401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N; Cambou JP; Hanania G; Kadri Z; Genès N; Lablanche JM; Blanchard D; Vaur L; Clerson P; Guéret P;
    Am Heart J; 2005 Dec; 150(6):1147-53. PubMed ID: 16338251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized approach to the management of coronary heart disease: identifying the nonresponders before it is too late.
    Ganz P; Hsue PY
    J Am Coll Cardiol; 2009 Jan; 53(4):331-3. PubMed ID: 19161881
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacotherapy following myocardial infarction].
    Spinarová L; Spinar J; Vítovec J
    Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Roth MT; Pieper JA
    Ann Pharmacother; 2003 Dec; 37(12):1867-76. PubMed ID: 14632542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention in chronic coronary heart disease].
    Hunziker P; Bertel O
    Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
    Jaumdally R; Lip GY; Varma C
    Int J Clin Pract; 2005 Sep; 59(9):1070-81. PubMed ID: 16115184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unrecognized myocardial infarction].
    Matsumoto T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():249-52. PubMed ID: 17952999
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.